PEAK6 Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$8.24M	Sell	87,517 -28,857	-25%	-$2.53M	0.04%	533
2018 Q1	$9.43M	Buy	116,374 +59,510	+105%	+$5.11M	0.04%	478
2017 Q4	$5.07M	Buy	56,864 +36,698	+182%	+$3.19M	0.02%	808
2017 Q3	$1.88M	Buy	20,166 +9,162	+83%	+$810K	0.01%	1444
2017 Q2	$999K	Sell	11,004 -48,970	-82%	-$4.46M	0.01%	1927
2017 Q1	$5.26M	Buy	59,974 +34,417	+135%	+$3.06M	0.04%	548
2016 Q4	$2.12M	Buy	+25,557	New	+$2.2M	0.02%	1268
2016 Q3	–	Sell	-11,193	Closed	-$1.05M	–	4311
2016 Q2	$871K	Buy	+11,193	New	+$952K	0.01%	1912
2016 Q1	–	Sell	-42,706	Closed	-$3.47M	–	4407
2015 Q4	$4.47M	Sell	42,706 -25,812	-38%	-$2.7M	0.03%	804
2015 Q3	$7.22M	Buy	68,518 +9,456	+16%	+$1.26M	0.04%	659
2015 Q2	$8.08M	Buy	59,062 +39,407	+200%	+$4.88M	0.05%	544
2015 Q1	$2.45M	Buy	+19,655	New	+$2.08M	0.02%	1112
2014 Q4	–	Sell	-41,549	Closed	-$3.46M	–	4660
2014 Q3	$3M	Buy	41,549 +20,549	+98%	+$1.35M	0.02%	952
2014 Q2	$1.31M	Buy	21,000 +11,500	+121%	+$695K	0.01%	1417
2014 Q1	$648K	Buy	9,500 +100	+1%	+$7.37K	0.01%	2291
2013 Q4	$661K	Buy	+9,400	New	+$638K	﹤0.01%	2421
2013 Q3	–	Sell	-2,500	Closed	-$166K	–	5103
2013 Q2	$139	Buy	+2,500	New	+$156K	﹤0.01%	3896